吖啶基甲磺酰苯胺（AMSA）系列三种同系物的实验抗肿瘤特性 - Suppr

Suppr

超能文献

The experimental antitumour properties of three congeners of the acridylmethanesulphonanilide (AMSA) series.

作者信息

Cain B F, Atwell G J

出版信息

Eur J Cancer (1965). 1974 Aug;10(8):539-49. doi: 10.1016/0014-2964(74)90079-6.

DOI:10.1016/0014-2964(74)90079-6

PMID:4463003

Abstract

摘要

相似文献

The experimental antitumour properties of three congeners of the acridylmethanesulphonanilide (AMSA) series.吖啶基甲磺酰苯胺（AMSA）系列三种同系物的实验抗肿瘤特性

Eur J Cancer (1965). 1974 Aug;10(8):539-49. doi: 10.1016/0014-2964(74)90079-6.

Antitumour activity of some cyclophosphazenes.某些环磷腈的抗肿瘤活性。

Eur J Cancer (1965). 1979 May;15(5):637-43. doi: 10.1016/0014-2964(79)90137-3.

Oral absorption and selective tissue localization of 4'-(9-acridinylamino)-methanesulfon-m-anisidide.4'-（9-吖啶基氨基）-甲磺基间茴香胺的口服吸收及选择性组织定位

Pharmacology. 1978;16(4):206-13. doi: 10.1159/000136768.

Combination chemotherapy with AMSA on L1210 leukaemia and B16 melanoma.氨茴霉素联合化疗治疗L1210白血病和B16黑色素瘤。

Eur J Cancer Clin Oncol. 1981 Sep;17(9):1017-21. doi: 10.1016/s0277-5379(81)80007-7.

Enhancement of antitumor effectiveness of ICRF-159 (NSC-129943) against early L1210 leukemia by combination with cis-diamminedichloroplatinum (NSC-119875) or daunomycin (NSC-82151).通过与顺二氨二氯铂（NSC - 119875）或柔红霉素（NSC - 82151）联合使用增强ICRF - 159（NSC - 129943）对早期L1210白血病的抗肿瘤效果。

Cancer Chemother Rep 2. 1974 Mar;4(1):45-52.

Activity of a novel anthracenyl bishydrazone, 9,10-anthracenedicarboxyaldehyde Bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride, against experimental tumors in mice.新型蒽基双腙9,10-蒽二甲醛双[(4,5-二氢-1H-咪唑-2-基)腙]二盐酸盐对小鼠实验性肿瘤的活性

Cancer Res. 1982 Feb;42(2):440-4.

Antitumor activity of 5-formamido-1- D-ribofuranosylthioimidazole-4-carboxamide 2',3',5'-triformate in a variety of animal tumors.5-甲酰胺基-1-D-呋喃核糖硫代咪唑-4-甲酰胺2',3',5'-三甲酸酯在多种动物肿瘤中的抗肿瘤活性

Cancer Chemother Rep. 1971 Jun;55(3):229-31.

Antitumor activity of cyclocytidine in a variety of tumors.环胞苷在多种肿瘤中的抗肿瘤活性。

Gan. 1972 Jun;63(3):353-60.

Effects of 4,4'-diacetyl-diphenyl-urea-bis(guanylhydrazone) on leukemia L1210.4,4'-二乙酰基二苯基脲双（胍腙）对白血病L1210的作用

Cancer Res. 1968 Feb;28(2):354-62.

In vivo and in vitro anticancer activity of the structurally novel and highly potent antibiotic CI-940 and its hydroxy analog (PD 114,721).结构新颖且高效的抗生素CI-940及其羟基类似物（PD 114,721）的体内和体外抗癌活性

Cancer Chemother Pharmacol. 1986;16(2):95-101. doi: 10.1007/BF00256156.

引用本文的文献

DNA-Binding Anticancer Drugs: One Target, Two Actions.DNA 结合型抗癌药物：一靶两用。

Molecules. 2021 Jan 21;26(3):552. doi: 10.3390/molecules26030552.

Accelerating the discovery of antibacterial compounds using pathway-directed whole cell screening.利用途径导向的全细胞筛选加速抗菌化合物的发现。

Bioorg Med Chem. 2016 Dec 15;24(24):6307-6314. doi: 10.1016/j.bmc.2016.08.003. Epub 2016 Aug 16.

Δ122p53, a mouse model of Δ133p53α, enhances the tumor-suppressor activities of an attenuated p53 mutant.Δ122p53（Δ133p53α的一种小鼠模型）增强了一种弱化型p53突变体的肿瘤抑制活性。

Cell Death Dis. 2015 Jun 11;6(6):e1783. doi: 10.1038/cddis.2015.149.

In vivo and in vitro assessment of the action of SN 28049, a benzonaphthyridine derivative targeting topoisomerase II, on the murine Colon 38 carcinoma.体内和体外评估苯并萘啶衍生物 SN 28049 对拓扑异构酶 II 的作用对鼠结肠 38 癌的影响。

Invest New Drugs. 2011 Dec;29(6):1504-10. doi: 10.1007/s10637-010-9509-0. Epub 2010 Aug 10.

Action of SN 28049, a new DNA binding topoisomerase II-directed antitumour drug: comparison with doxorubicin and etoposide.新型 DNA 结合拓扑异构酶 II 靶向抗肿瘤药物 SN 28049 的作用：与多柔比星和依托泊苷的比较。

Invest New Drugs. 2011 Oct;29(5):1102-10. doi: 10.1007/s10637-010-9473-8. Epub 2010 Jun 22.

Chemotherapeutic potential of 9-phenyl acridine: biophysical studies on its binding to DNA.9-苯基吖啶的化疗潜力：与 DNA 结合的生物物理研究。

Eur Biophys J. 2010 Jul;39(8):1243-9. doi: 10.1007/s00249-010-0577-z. Epub 2010 Feb 5.

DNA binding-independent anti-proliferative action of benzazolo[3,2-alpha]quinolinium DNA intercalators.苯并唑并[3,2-α]喹啉鎓DNA嵌入剂的不依赖DNA结合的抗增殖作用

Mol Cell Biochem. 1997 Dec;177(1-2):69-77. doi: 10.1023/a:1006857118469.

Novel carbamate analogues of amsacrine with activity against non-cycling murine and human tumour cells.具有抗静止期小鼠和人肿瘤细胞活性的氨吖啶新型氨基甲酸酯类似物。

Cancer Chemother Pharmacol. 1994;34(2):159-65. doi: 10.1007/BF00685934.

A phase I and II study of m-AMSA in acute leukaemia.米托蒽醌治疗急性白血病的Ⅰ/Ⅱ期研究。

Cancer Chemother Pharmacol. 1981;6(2):137-40. doi: 10.1007/BF00262331.

Clonal variation in the sensitivity of B16 melanoma to m-AMSA.B16黑色素瘤对m-AMSA敏感性的克隆变异

Br J Cancer. 1982 Jun;45(6):821-9. doi: 10.1038/bjc.1982.133.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验